Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:13:39.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T10:14:53.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    No new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.
    Difference
    14%
    Check dated 2024-11-23T03:49:54.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    A new study on Gilteritinib in combination with Ivosidenib or Enasidenib for Acute Myeloid Leukemia has been added, while a previous study from September 2024 has been removed.
    Difference
    1%
    Check dated 2024-11-15T22:20:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.
    Difference
    16%
    Check dated 2024-11-08T17:53:57.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T10:20:23.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.